2025-11-17T16:01:58-05:00 2024-12-31 061354191 VISCONTI & ASSOCIATES PC 444 FOXON ROAD EAST HAVEN CT 06513 990 2024-01-01 372120626 RENEGADE RESEARCH % ISABEL BURNETT RENE 9760 NATURE VALLEY DR BRIGHTON MI 48114 ISABEL BURNETT DIRECTOR 2025-11-07 true true JOHN J VISCONTI P00027180 2038652927 2025-11-17 2024 2025-03-06 01:10:19Z X 159837 false X WWW.RENEGADE-RESEARCH.ORG X 2024 CO RENEGADE RESEARCH IS DRIVEN BY THE VISION TO EMPOWER CHRONIC ILLNESS PATIENTS THROUGH COLLABORATIVE RESEARCH AND INNOVATIVE SELF-EXPERIMENTATION. OUR MISSION IS CENTERED ON PIONEERING ACCESSIBLE PATIENT-LED EFFORTS TO UNCOVER SCIENTIFIC INSIGHTS & IMPROVE OVERALL QUALITY OF LIFE 5 5 0 30 0 0 159837 0 0 0 159837 0 0 0 0 0 134050 134050 25787 25787 0 25787 X RENEGADE RESEARCH IS DRIVEN BY THE VISION TO EMPOWER CHRONIC ILLNESS PATIENTS THROUGH COLLABORATIVE RESEARCH AND INNOVATIVE SELF-EXPERIMENTATION. OUR MISSION IS CENTERED ON PIONEERING ACCESSIBLE PATIENT-LED EFFORTS TO UNCOVER SCIENTIFIC INSIGHTS & IMPROVE OVERALL QUALITY OF LIFE false false 119297 REMISSION BIOME RESEARCH IS AN EXPERIMENTAL, MEDICALLY SUPERVISED, PROTOCOL TITLED REMISSION BIOME TO HELP PATIENTS WITH ME/CFS (MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME) AND LONG COVID TO POTENTIALLY ACHIEVE A HIGHER BASELINE IN FUNCTION AND IMPROVE THEIR QUALITY OF LIFE. OUR INITIAL RESULTS ARE ENCOURAGING AND AT PRESENT, WE ARE EXPANDING THE SCOPE OF THIS PROJECT TO INCLUDE MORE PATIENTS. 6189 PUBLIC EDUCATION SEMINARS ARE TO HOST RESEARCH AND CLINICAL EDUCATIONAL SEMINARS ABOUT ME/CFS (MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME), LONG COVID, AND RELATED CONDITIONS FOR RESEARCHERS, CLINICIANS, AND THE PUBLIC TO ATTEND. THESE SEMINARS ARE RECORDED AND POSTED ON OUR YOUTUBE CHANNEL FOR PUBLIC VIEWING FROM PEOPLE WHO CANNOT ATTEND REAL TIME. 337 LACTATE TESTING AND RESEARCH IN A RESEARCH PROJECT THAT IS LED BY INDIVIDUALS WITH ME/CFS (MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME), LONG COVID, PERFORMING SELF-EXPERIMENTATION TO TEST A HYPOTHESIS, ANALYZE THE DATA, REVIEW THEIR HYPOTHESIS AND CONTINUE AS THE DATA GUIDES THEM. THIS WAS BASED ON PREVIOUS RESEARCH OF HIGH LACTATE LEVELS IN PATIENTS. THE RESULTS WILL BE SHARED IN AN OPEN-SOURCE FORMAT. A PUBLICATION IS CURRENTLY BEING WRITTEN. 125823 true true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true 2 0 true 0 false false false false false false false false false false false false false false X 5 5 false true false false false false false true true false false true true true true false false false false false CO X X STEW CASOLA 2039162181 1860 W 68TH AVE DENVER CO 80221 X ISABEL BURNETT DIRECTOR 1.00 0.00 X 0 0 0 TESS FALOR DIRECTOR 1.00 0.00 X 0 0 0 MARIE JOBIN PRESIDENT 1.00 0.00 X X 0 0 0 SHELLEY HAYDEN SECRETARY 1.00 0.00 X X 0 0 0 ANA SOFIA PINHO TREASURER 1.00 0.00 X X 0 0 0 0 0 0 0 false false false 159837 159837 0 159837 0 0 0 90751 90751 4473 934 3539 8586 4921 3665 389 389 2135 1156 979 RESEARCH SUPPLIES 23365 23365 RESEARCH TECH 4351 4307 44 134050 125823 8227 0 25456 331 0 25787 0 0 X 25787 0 25787 0 25787 25787 0 X false false false X 159837 159837 159837 159837 153443 6394 159837 0.04000 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED Management duties delegation Part VI line 3 MANAGEMENT DUTIES WERE CONTRACTED FOR THE BENEFIT OF THE AGENCY, AS IT IS NEW AND DEVELOPING. Form 990 governing body review Part VI line 11 THE FORM 990 IS REVIEWED BY THE BOARD OF DIRECTORS BEFORE EFILING. Conflict of interest policy compliance Part VI line 12c A CONFLICT OF INTEREST POLICY WAS ADOPTED BY THE BOARD OF DIRECTORS IN 2024 AND CONFLICTS ARE REQUIRED TO BE DISCLOSED. THE POLICY AND COMPLIANCE IS REVIEWED ANNUALLY. Governing documents etc available to public Part VI line 19 INFORMATION IS MADE AVAILABLE TO THE PUBLIC UPON REQUEST. Part III response or note to any other line in Part III FOR OUR GLOBAL COMMUNITY. WE BELIEVE THAT BY WORKING TOGETHER, WE CAN MAKE A POSITIVE CHANGE IN THE LIVES OF THOSE AFFECTED BY CHRONIC ILLNESSES.